Cantor Fitzgerald, L. P. Legend Biotech Corp Transaction History
Cantor Fitzgerald, L. P.
- $8.4 Billion
- Q3 2025
A detailed history of Cantor Fitzgerald, L. P. transactions in Legend Biotech Corp stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 10,000 shares of LEGN stock, worth $302,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$302,900
Previous $326,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LEGN
# of Institutions
224Shares Held
57.2MCall Options Held
231KPut Options Held
626K-
Westfield Capital Management CO LP Boston, MA6.09MShares$185 Million0.91% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$181 Million5.86% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$173 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.82MShares$116 Million3.74% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$89.7 Million1.8% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.07B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...